Pharma exports from region up by over 60%

INDORE: Pharmaceutical exports from the region have registered a growth of over 60 per cent this year as against the previous year led by higher orders and up-gradation in firms.

According to data from Development Commissioner Special Economic Zone (SEZ), exports from pharmaceutical firms in fiscal year 2018/19 stood at Rs 3,771.54 crore, up 67.62 per cent as against Rs 2,249.93 crore in the past year.

An HR executive from a leading pharmaceutical company located in the Special Economic Zone (SEZ) said, “This year was extraordinary for us because the number of orders were high from our customers after we upgraded and passed certain international standards mandatory for exports.”

Pithampur has over 20 pharmaceutical companies and more new companies are expected to set up facilities in the region in coming years as the region has become the hub for pharmaceutical companies.

Another executive from a Pithampur based drug manufacturing unit said, “In comparison to other states, the cost of operations are economical here as companies are getting the SEZ benefits. Electricity is cheap, subsidies are there in addition to other facilities that makes the companies competitive.”

Industrialists said opportunities are huge for pharmaceutical companies in the region as the cost of operations and labour are economical. They expect exports to grow further in the next year.

Industrialists said, the contribution of small-scale drug manufacturers are negligible in exports and to promote them some additional subsidies to help them bear the up-gradation costs should be provided.

Indore has over 120 small scale medicines manufacturing units engaged in production of sanitizers, ointments, syrups and injectable with over 10 units engaged in exports contributing about Rs 500 crore annual exports.

Alok Dave, president, Association of Industries Madhya Pradesh (AIMP) said, “Subsidies and financial assistance will help in increasing exports from small-scale drug manufacturers. The government should also develop a cluster to curtail the cost of operations of small manufacturers.”

  • Related Posts

    • Pharma
    • June 27, 2025
    • 176 views
    Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

    Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners,…

    • Pharma
    • June 27, 2025
    • 161 views
    Sun Pharma ropes in Richard Ascroft as North America CEO

    Mumbai: Sun Pharma has announced the appointment of Richard Ascroft as the new North America (NAM) Chief Executive Officer (CEO). In a statement shared via LinkedIn, the company said, “We…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

    Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

    Sun Pharma ropes in Richard Ascroft as North America CEO

    Sun Pharma ropes in Richard Ascroft as North America CEO

    Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

    Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen